Skip to content

Examination of the effects of renal rehabilitation treatment on kidney transplantation patients

Examination of the effects of renal rehabilitation treatment on kidney transplantation patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1050220180
Enrollment
30
Registered
2023-02-28
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation End stage renal disease

Interventions

Renal rehabilitation(aerobic exercise, resistance exercise, virtual reality training) Cardio Pulmonary Exercise test Body Composition Analyzer Questionnaire for health related quality of life, and phy

Sponsors

Domen Kazuhisa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who undergo kidney transplantation at the Department of Urology, Hyogo Medical University Hospital 2. Written informed consent from the patient for study participation 3. Age 20 or older at the time consent is obtained 4. Patients who understand and can parform renal rehabilitation treatment

Exclusion criteria

Exclusion criteria: 1. Patient who refused renal rehabilitation treatment 2. Patients with acute myocardial infarction 3. Patients with poorly controlled unstable angina pectoris 4. Patients with poorly controlled arrhythmia 5. Patients with severe aortic stenosis 6. Patients with poorly controlled Heart failure 7. Patients with acute pulmonary embolism or pulmonary infarction 8. Patients with acute myocarditis or pericarditis 9. Patients with acute aortic dissection 10. Patients with mental illness who cannot communicate 11. Patients with poorly controlled hypertension (systolic blood pressure >= 180 mmHg, diastolic blood pressure >= 100 mmHg) 12. Patients with electrolyte imbalance (postoperative serum potassium >=5.5 mEq/L) 13. Patients who are judged unsuitable as subjects by the principal investigator or subinvestigator

Design outcomes

Primary

MeasureTime frame
6-minute walk distance

Secondary

MeasureTime frame
Peak VO2(maximum VO2), Anaerobic Threshold Gait Speed Short Physical Performance Battery(as follows: SPPB) Knee extension strength eGFR, HGB, Alb Echocardiography(left ventricular ejection fraction measured, left ventricular end diastolic diameter measured, left atrium diameter measured, left atrium volume measured, E/e' measured) Ankle brachial pressure index/Pulse Wave Velocity(as follows: ABI/PWV) Skeletal Muscle mass Index(as follows: SMI) health-related quality of life, physical activities

Contacts

Public ContactMasashi Ichikawa

Hyogo Medical University Hospital

ma-ichikawa@hyo-med.ac.jp+81-798-45-6881

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026